Therapie des Vorhofflimmerns: medikamentös, katheterbasiert oder operativ? Pro Katheter

Vorhofflimmern - Katheterablation

atrial fibrillation - catheter ablation

Literatur

• 1 Cappato R, Calkins H, Chen S A. et al . Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.  Circulation. 2005;  111 1100-1105
• 2 Cappato R, Calkins H, Chen S A. et al . Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation.  J Am Coll Cardiol. 2009;  53 1798
• 3 Corley S D, Epstein A E, DiMarco J P. et al, AFFIRM Investigators . Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.  Circulation. 2004;  109 1509-1513
• 4 Khaykin Y, Wang X, Natale A, Wazni O M, Skanes A C, Humphries K H, Kerr C R, Verma A, Morillo C A. Cost comparison of ablation versus antiarrhythmic drugs as first-line therapy for atrial fibrillation: an economic evaluation of the RAAFT pilot study.  J Cardiovasc Electrophysiol. 2009;  20 7-12
• 5 Lafuente-Lafuente C, Mouly S, Longás-Tejero M A, Mahé I, Bergmann J F. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.  Arch intern Med. 2006;  166 719-728
• 6 Nair G M, Nery P B, Diwakaramenon S, Healey J S, Connolly S J, Morillo C A. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation.  J Cardiovasc Electrophysiol. 2009;  20 138-144
• 7 Pappone C, Rosanio S, Augello G. et al . Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study.  J Am Coll Cardiol. 2003;  42 185-197